Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors

Journal of Thrombosis and Haemostasis(2024)10.1016/j.jtha.2024.07.023Source: DataRank Database

Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors is a research paper published in Journal of Thrombosis and Haemostasis (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.59)OA: bronzeTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jing Li ORCID,Jocelyn A. Schroeder ORCID,Weiqing Jing ORCID,Qizhen Shi ORCID,Yingyu Chen ORCID

Live enrichment

PubMed:39127324 PMC:PMC11513242 OpenAlex:https://openalex.org/W4401418535

National Heart, Lung, and Blood Institute

Grant: HL-102035

Natural Science Foundation of Fujian Province

Grant: 2020J01996

NHLBI NIH HHS

Grant: R01 HL102035

National Institutes of Health

FWCI

0.59

Citation Percentile

0.7%

Citation Trend

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jthjournal.org/article/S1538783624004434/pdf

publisherhttp://www.jthjournal.org/article/S1538783624004434/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783624004434?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783624004434?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2024.07.023

Fields of Study

Hemophilia Treatment and ResearchVirus-based gene therapy researchPlatelet Disorders and TreatmentsAnimalsHemophilia AGenetic TherapyMiceBlood PlateletsBusulfanFactor VIIIHumansHematopoietic Stem Cell TransplantationVidarabineTransplantation ConditioningDisease Models, AnimalLentivirusMice, Inbred C57BL

MeSH Terms

AnimalsBlood PlateletsBusulfanDisease Models, AnimalFactor VIIIHemophilia AHumansMice, Inbred C57BLVidarabineGenetic TherapyLentivirusHematopoietic Stem Cell TransplantationTransplantation ConditioningMice

Keywords

MelphalanBusulfanGenetic enhancementMedicineFludarabineHematopoietic stem cell transplantationPlateletTransplantationPharmacologyHematopoietic cellImmunologyHaematopoiesisCancer researchStem cellChemotherapyGeneInternal medicineCyclophosphamideBiologyGeneticsGene therapyInhibitorPreconditioningHemophilia A

Sustainable Development Goals

SDG 0: Zero hunger